BioSpace News Archive

BioCapital

Xtant Medical Announces Compliance With NYSE American

The Company will continue to trade on the NYSE American exchange under the symbol “XTNT”.

February 16, 2018

·

4 min read

Business

Origin Agritech Appoints James Chen as CEO

Origin Agritech Limited today announced the Board of Directors has appointed Dr. Z. James Chen to be the Chief Executive Officer effective on March 1, 2018.

February 16, 2018

·

4 min read

BioAmber Receives Notice of Delisting by TSX

These measures were taken due to the Company not meeting the continued listing requirements of the TSX.

February 16, 2018

·

3 min read

Deals

Seattle Genetics Announces Expiration of Hart-Scott-Rodino Waiting Period

Seattle Genetics announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to Seattle Genetics’ proposed acquisition of Cascadian Therapeutics, Inc. (NASDAQ:CASC) expired at 11:59 p.m. on February 15, 2018.

February 16, 2018

·

7 min read

Stryker Nabs FDA OK for Cementless Mako Total Knee

FDA

AMAG Investors Cheer as Biotech Wins Second Drug Approval This Month

Makena was approved by the FDA in February 2011 and remains the first and only FDA-approved treatment option currently available for pregnant women who have had a prior spontaneous preterm birth.

February 16, 2018

·

11 min read

Lone Star Bio

Caris Life Sciences Announces Published Results Validating its Next-Generation Sequencing Platform to Detect Microsatellite Instability and Comparing Immunotherapy Associated Biomarkers across 11,000 Patients

The study evaluated 2,189 cases that spanned 26 cancer types, of which 1,108 were colorectal cancer, to compare mismatch repair status of Caris’ NGS platform to the current industry standard of PCR-FA.

February 16, 2018

·

4 min read

PharmaMar Has Published the Results of its Antibody Conjugate Active in Breast, Ovarian and Gastric Cancers that Express HER2

PharmaMar has announced the positive results of MI130004, a novel antibody conjugate combining trastuzumab with PM050489, a molecule of marine origin.

February 16, 2018

·

1 min read

Biotech Beach

Evid Science Receives Seed Capital to Advance Clinical AI Platform

Evid Science has successfully secured seed funding from TKS I, a new private equity fund dedicated to early stage life science companies.

February 16, 2018

·

3 min read

Business

Aziyo and Cook Biotech Announce Further Expansion of the Bio Envelope Franchise into Additional Markets

Aziyo Biologics, Inc. and Cook Biotech Inc. today announced the expansion of the Aziyo Bio Envelope franchise by entering into additional exclusive global license agreements expanding the applications for the Bio Envelope product into the field of neuromodulation.

February 16, 2018

·

3 min read

Biotech Beach

DermTech’s Collaborators Present Research Studies at AAD Supporting the Use of “Adhesive Patch Skin Biopsy” in Cutaneous Basal Cell and Squamous CellCarcinoma

DermTech announced today the presentation of two studies at the 76th Annual Meeting of the American Academy of Dermatology (AAD) in San Diego.

February 16, 2018

·

2 min read